Vandna Shah

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

Andrew Tutt, Holly Tovey, Maggie C.U. Cheang et al. · Nature Medicine · 2018 · 903 citations · Full text

Medicine, Oncology, Pharmacology +11

The proteasomal de‐ubiquitinating enzyme POH1 promotes the double‐strand DNA break response

Laura Butler, Ruth M. Densham, Junying Jia et al. · The EMBO Journal · 2012 · 162 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers

Johnathan Watkins, Daniel Weekes, Vandna Shah et al. · Cancer Discovery · 2015 · 113 citations · Full text

Medicine, Genetics, Oncology +17

Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer

Esther H. Lips, Tapsi Kumar, Anargyros Megalios et al. · Nature Genetics · 2022 · 92 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Genetic predisposition to ductal carcinoma in situ of the breast

Christos Petridis, Mark N. Brook, Vandna Shah et al. · Breast Cancer Research · 2016 · 64 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17